Overview


Fibrin sealant is a biological agent that is used to control bleeding in surgeries or injuries where ligation, suturing or cautery does not provide enough haemostasis. Fibrin is a mixture of thrombin or fibrinogen which is applied to the affected area in order to prevent haemorrhage. Additionally, a permanent factor for regional growth is also delivered by fibrin as it is also used as a delivery device. It is also an excellent blood clotting agent and it can also do tissue sealing so that it can prevent serious fluid accumulation or lymphatic leak. Considering all these properties, fibrin sealant is an ideal component for reducing fluid accumulation, ecchymoses, hematomas, swelling etc. Perhaps, it also eliminates the need for drains after rhytidectomy.
Fibrin sealant market is primarily driven by increasing prevalence of invasive surgeries and traumatic injuries. Recent advancements have led to the development of biocompatible sealants which decreased the complications and allow normal movement of tissues without any interference on the functioning of the organs. Traditionally, sutures/wires/staples are used for wound sealing and they pose significant threats like tissue damage, infection and delayed the repair of the tissue. Due to the rapid advancements of technologies, traditional methods are replaced by sealants and let to the burgeoning growth of the market. Among the different types of sealants, synthetic adhesives offer high mechanical and adhesive strength. These features made the synthetic surgical sealants most attractive segment over natural sealants and expected to witness significant growth during the forecast period. All these factors have led to the potential growth of the market.
Market is dominated by the Asia Pacific due to the high prevalence of traumatic injuries and invasive surgeries. It is expected to gain more traction during the forecast period due to increasing prevalence. It is followed by North America and it dominated by the US due to high dollar opportunity. Europe is the third major shareholder in the global market due to increasing incidence during the forecast period. Latin America and Rest of World are the fast growing regions due to increasing adoption among the end user segment. They account a small fraction of the global market and expected to increase traction during the forecast period.
• Baxter
• Pfizer Inc.
• Takeda Pharmaceutical Company
• Johnson
Johnson (Ethicon, Inc.)
• Grifols, S.A.
• CSL Limited
• Vivostat A/S
• Stryker
• Hemarus
• Asahi Kasei Corporation
(Note: The list of the major players will be updated with the latest market scenario and trends)
By Product Type
• Liquid
• Patches
By Application
• Orthopedic Surgery
• Cardiovascular surgery
• General Surgery
• Transplant Surgery
• Others
By End User
• Hospitals
• Specialty Clinics
• Others
By Region
• North America
• Latin America
• Europe
• Asia-Pacific
• Middle East and Africa
•
Tier 1 players- established companies in the market with a major market share
•
Tier 2 players
•
Emerging players which are growing rapidly
•
New Entrants
•
Growth prospects
•
SWOT analysis
•
Key trends
•
Key data-points affecting market growth
•
To provide with an exhaustive analysis on the global Fibrin Sealant Market By Type, By Application, By End User, by Region
•
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•
To evaluate and forecast micro-markets and the overall market
•
To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
•
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
•
Profiling of companies to evaluate their market shares, strategies, financials and core competencies
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Fibrin Sealant Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances
  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Fibrin Sealant Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Fibrin Sealant Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Fibrin Sealant Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Liquids
        2. Patches
  • 8.   Global Fibrin Sealant Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Orthopedic Surgery
        2. Cardiovascular surgery
        3. General Surgery
        4. Transplant Surgery
        5. Others
  • 9.   Global Fibrin Sealant Market, By End user Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Hospitals
        2. Specialty Clinics
        3. Others
  • 10.   North America Fibrin Sealant Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
           2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2022-2028
  • 11.   Latin America Fibrin Sealant Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2022-2028
  • 12.   Europe Fibrin Sealant Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2022-2028
  • 13.   Asia Pacific Fibrin Sealant Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
  • 14.   Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2022-2028
  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Baxter
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
         2. Pfizer Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Takeda Pharmaceutical Company
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Johnson
  • 17.  Johnson (Ethicon, Inc.)
    •    16.4.1. Company Overview
         16.4.2. Product Portfolio
         16.4.3. SWOT Analysis
         16.4.4. Financial Overview
         16.4.5. Strategic Overview
          16.5. Grifols, S.A.
         16.5.1. Company Overview
         16.5.2. Product Portfolio
         16.5.3. SWOT Analysis
         16.5.4. Financial Overview
         16.5.5. Strategic Overview
        16.6. CSL Limited
         16.6.1. Company Overview
         16.6.2. Product Portfolio
         16.6.3. SWOT Analysis
         16.6.4. Financial Overview
         16.6.5. Strategic Overview
        16.7. Vivostat A/S
         16.7.1. Company Overview
         16.7.2. Product Portfolio
         16.7.3. SWOT Analysis
         16.7.4. Financial Overview
         16.7.5. Strategic Overview
        16.8. Stryker
         16.8.1. Company Overview
         16.8.2. Product Portfolio
         16.8.3. SWOT Analysis
         16.8.4. Financial Overview
         16.8.5. Strategic Overview
        16.9. Hemarus
         16.9.1. Company Overview
         16.9.2. Product Portfolio
         16.9.3. SWOT Analysis
         16.9.4. Financial Overview
         16.9.5. Strategic Overview
        16.10.Asahi Kasei Corporation
         16.10.1. Company Overview
         16.10.2. Product Portfolio
         16.10.3. SWOT Analysis
         16.10.4. Financial Overview
         16.10.5. Strategic Overview
  • 18.   Pre and Post COVID-19 Impact
    •   17.1. Positive influence on the healthcare industry
        17.2. The financial disruption of the manufacturing sector
        17.3. Impact of COVID-19 on emerging companies
        17.4. Significant mandates in the regulations initiated by healthcare administrations
        17.5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11